z-logo
open-access-imgOpen Access
Posterior Reversible Encephalopathy Syndrome (PRES) in a Patient with Opioid Use Disorder
Author(s) -
Terence Tumenta,
Samuel Adeyemo,
Oluwatoyin Oladeji,
Oluwole Jegede,
Bordes Laurent,
Tolu Olupona
Publication year - 2021
Publication title -
case reports in psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.17
H-Index - 4
eISSN - 2090-682X
pISSN - 2090-6838
DOI - 10.1155/2021/9999481
Subject(s) - medicine , posterior reversible encephalopathy syndrome , headaches , neurology , stupor , reversible cerebral vasoconstriction syndrome , etiology , white matter , pediatrics , anesthesia , toxic encephalopathy , encephalopathy , magnetic resonance imaging , psychiatry , subarachnoid hemorrhage , radiology
Posterior Reversible Encephalopathy Syndrome (PRES) is a characteristic clinical radiographic syndrome with diffuse structural alteration of cerebral white matter secondary to myelin damage with diverse and multifactorial etiologies. It can present with acutely altered mentation, somnolence or occasionally stupor, vision impairment, seizures, and sudden or chronic headaches that are not focal. The pathophysiology remains unclear, but mechanisms involving endothelial injury and dysregulation of cerebral autoregulation have been purported. We report the case of a 36-year-old male with a history of heroin use disorder, who was admitted to our hospital for opioid withdrawal. CT head without contrast and MRI with and without gadolinium showed significant white matter disease in both cerebral hemispheres and cerebellum. He was diagnosed with Posterior Reversible Encephalopathy Syndrome secondary to heroin use and managed on the medical floor in collaboration with the neurology team. His clinical symptoms improved and he was discharged after six weeks. To our knowledge, this case did not present with the risk factors for PRES reported in the literature. For patients with heroin use disorder who present with an altered mental status, PRES should be highly suspected. The diagnosis and management require collaboration between psychiatry and neurology.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom